One year in review 2018: novelties in the treatment of rheumatoid arthritis

被引：1
|
作者：
Bortoluzzi, A. [1 ]
Furini, F. [1 ]
Generali, E. [2 ]
Silvagni, E. [1 ]
Luciano, N. [3 ]
Scire, C. A. [1 ,4 ]
机构：
[1] Univ Ferrara, Rheumatol Unit, Dept Med Sci, Ferrara, Italy
[2] Humanitas Clin & Res Ctr, Div Rheumatol & Clin Immunol, Milan, Italy
[3] Univ Pisa, Rheumatol Unit, Dept Clin & Expt Med, Pisa, Italy
[4] Italian Soc Rheumatol, Epidemiol Unit, Milan, Italy
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2018年 / 36卷 / 03期
关键词：
rheumatoid arthritis; biologics; treatment; management; TUMOR-NECROSIS-FACTOR; MODIFYING ANTIRHEUMATIC DRUGS; LONG-TERM EFFECTIVENESS; RANDOMIZED PHASE IIB; LOW DISEASE-ACTIVITY; DOUBLE-BLIND; OPEN-LABEL; MONOCLONAL-ANTIBODY; CLINICAL-OUTCOMES; INADEQUATE RESPONSE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The current approach to treatment of rheumatoid arthritis (RA) includes early and aggressive intervention aiming to reach early and persistent low disease activity and remission. New drugs have improved the therapeutic armamentarium of rheumatologists, providing new options for patients. Beyond these innovations, new evidence has improved the safety of therapies and provided tools for the optimisation of long-term management of RA. This paper reviews the most relevant studies published over the last year in the field of treatment of RA.
引用
收藏
页码：347 / 361
页数：15
相关论文
共 50 条
  • [21] One year in review 2019: pathogenesis of rheumatoid arthritis
    Croia, Cristina
    Bursi, Roberto
    Sutera, Donatella
    Petrelli, Fiorella
    Alunno, Alessia
    Puxeddu, Ilaria
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : 347 - 357
  • [22] A review of sarilumab for the treatment of rheumatoid arthritis
    Lee, Eun Bong
    IMMUNOTHERAPY, 2018, 10 (01) : 57 - 65
  • [23] Review of tocilizumab in the treatment of rheumatoid arthritis
    Okuda, Yasuaki
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01) : 75 - 82
  • [24] One year in review 2020: pathogenesis of rheumatoid arthritis
    Giannini, D.
    Antonucci, M.
    Petrelli, F.
    Bilia, S.
    Alunno, A.
    Puxeddu, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (03) : 387 - 397
  • [25] One year in review 2021: pathogenesis of rheumatoid arthritis
    Testa, D.
    Calvacchi, S.
    Petrelli, F.
    Giannini, D.
    Bilia, S.
    Alunno, A.
    Puxeddu, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (03) : 445 - 452
  • [26] Pathogenesis of rheumatoid arthritis: one year in review 2024
    D'Orazio, A.
    Cirillo, A. L.
    Greco, G.
    Di Ruscio, E.
    Latorre, M.
    Pisani, F.
    Alunno, A.
    Puxeddu, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 1707 - 1713
  • [27] Pathogenesis of rheumatoid arthritis: one year in review 2022
    Petrelli, F.
    Mariani, F. M.
    Alunno, A.
    Puxeddu, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (03) : 475 - 482
  • [28] One year in review 2017: pathogenesis of rheumatoid arthritis
    Angelotti, F.
    Parma, A.
    Cafaro, G.
    Capecchi, R.
    Alunno, A.
    Puxeddu, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (03) : 368 - 378
  • [29] Pathogenesis of rheumatoid arthritis: one year in review 2023
    Mariani, F. M.
    Martelli, I.
    Pistone, F.
    Chericoni, E.
    Puxeddu, I.
    Alunno, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (09) : 1725 - 1734
  • [30] Treatment of rheumatoid arthritis: Unraveling the conundrum
    Zampeli, Evangelia
    Vlachoyiannopoulos, Panayiotis G.
    Tzioufas, Athanasios G.
    JOURNAL OF AUTOIMMUNITY, 2015, 65 : 1 - 18
12345